Federal solicitation · 36F79726D0177 · back to recent
Alnylam Pharmaceuticals 09/01/2026 - 08/31/2031
VETERANS AFFAIRS, DEPARTMENT OF · NAICS 325412 · $387.8M est.
Similar opportunities
Other open SAM.gov opportunities under the same NAICS, prioritizing the same buying agency.
| Title | Agency | Est. value | Basis |
|---|---|---|---|
| Takeda Pharmaceuticals America, Inc. - Contract Award:... | VETERANS AFFAIRS, DEPARTMENT OF | $5,600.0M | same agency naics |
| Takeda Pharmaceuticals America, Inc. - Contract Award:... | VETERANS AFFAIRS, DEPARTMENT OF | $5,600.0M | same agency naics |
| Alkermes, Inc August 01, 2026 - July 31, 2031 | VETERANS AFFAIRS, DEPARTMENT OF | $1,675.1M | same agency naics |
| Ipsen Biopharmaceuticals, Inc., dba Tercica, Inc. 65IB... | VETERANS AFFAIRS, DEPARTMENT OF | $760.7M | same agency naics |
| Indivior, Inc. 05/15/2026 - 05/14/2031 | VETERANS AFFAIRS, DEPARTMENT OF | $748.9M | same agency naics |
| Budesonide/Formoterol INH | VETERANS AFFAIRS, DEPARTMENT OF | $436.5M | same agency naics |
| Blueprint Medicines, Corporation (PENDING PROPOSAL) | VETERANS AFFAIRS, DEPARTMENT OF | $394.1M | same agency naics |
| Daiichi Sankyo, Inc. OFF-FSS-7663, 36F79726D0162 | VETERANS AFFAIRS, DEPARTMENT OF | $250.0M | same agency naics |
Data this profile does NOT cover
- No likely incumbent surfaced; the solicitation number did not prefix-match any award in the FPDSAward window.
- No FPDSAward rows for NAICS 325412 in the trailing 12 months; vendor concentration unavailable.